Cargando…
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
The discovery of biomarkers in rare diseases is of paramount importance to allow a better diagnosis, improve predictions of outcomes, and prompt the development of new treatments. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a rare autoimmune disorder associated with the presence of an...
Autores principales: | Ciano-Petersen, Nicolás Lundahl, Cabezudo-García, Pablo, Muñiz-Castrillo, Sergio, Honnorat, Jérôme, Serrano-Castro, Pedro Jesús, Oliver-Martos, Begoña |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658717/ https://www.ncbi.nlm.nih.gov/pubmed/34884930 http://dx.doi.org/10.3390/ijms222313127 |
Ejemplares similares
-
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2022) -
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2023) -
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020) -
Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies
por: Aguilar-Castillo, María José, et al.
Publicado: (2022) -
Associations between HLA and autoimmune neurological diseases with autoantibodies
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2020)